Post-Op Gouty Arthritis Described in Patient Taking Thiazide

This article originally appeared here.
Share this content:
Post-Op Gouty Arthritis Described in Patient Taking Thiazide
Post-Op Gouty Arthritis Described in Patient Taking Thiazide

TUESDAY, April 19, 2016 (HealthDay News) -- A case of postoperative acute gouty arthritis following laparoscopic cholecystectomy with umbilical hernioplasty, secondary to hydrochlorothiazide use, has been documented in a case report published in the March issue in the Journal of Pharmacy Practice and Research.

M. Bhanukumar, M.B.B.S., M.D., from JSS University in Mysore, India, and colleagues reported a case of postoperative acute gouty arthritis secondary to use of hydrochlorothiazide in a 65-year-old woman. The patient developed pain in the left foot five days after laparoscopic cholecystectomy with umbilical hernioplasty, which was characterized by swelling, redness, and warmth in the dorsal aspect and tenderness at the first metatarsophalangeal joint. The patient had a history of hypertension and had been treated with hydrochlorothiazide for the past three years.

The authors note that the patient's condition was diagnosed as postoperative acute gouty arthritis secondary to thiazide intake, based on the presenting signs, symptoms, and past medical history. A possible relationship was suggested between symptoms and hydrochlorothiazide use in causality assessment. After the offending drug was withdrawn, symptoms improved significantly.

"This case report highlights the importance of monitoring the blood uric acid level pre- and postoperatively in an individual on thiazide diuretics," the authors write. "It also helps to create awareness of the various risk factors associated with gout."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »